Stock Analysis·← Pickers

COR

Cencora, Inc.

Cencora, Inc. (COR) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 63.8, with 1/3 trend checks passing.

Price
$307.99
+11.43 (+3.85%)
Day range
$298.73–$309.27
52wk $244.82–$377.54
Volume
1.3M
Avg
Trend score
1/3
Range / Mixed
RSI (14)
63.8
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

COR with MA50 and MA200

374.8344.2313.7283.2252.708/0110/2701/2304/2007/16
COR2025-08-012026-07-16
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$278.36+10.65% vs price
MA200
$324.62-5.12% vs price
RSI (14)
63.8Neutral zone
MACD Signal
BullishMomentum above signal
Macro Support
$269.30–$281.578.6% below price · 3 touches
Support Quality
3 touches1.2× zone volume
Valuation

COR valuation multiples (TTM)

P/E Ratio
P/S Ratio
P/B Ratio
EV/EBITDA
Valuation multiples are provided by Financial Modeling Prep when available.
Analyst Ratings

COR analyst consensus

Avg Price Target
High Target
Low Target
Analyst Coverage
Analyst ratings and price targets are provided by Financial Modeling Prep when available.
Chart Summary
Trend summary for COR

Cencora, Inc. (COR) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $307.99, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 10.6% and below the 200-day moving average by 5.1%.

Momentum and stretch context

COR currently has an RSI reading of 63.8, which leans mildly positive without looking too stretched. In other words, momentum is supportive, but not yet extreme enough to dominate the entire chart read.

What traders may watch next

This page is designed to help you quickly understand what the COR chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Cencora, Inc.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Share dilution

COR shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2019Mar 2026
Shares outstanding (latest)
194.5M
Since Jun 2019
-7.2%
Trend
Fewer shares outstanding (buybacks)
Historical shares-outstanding data from Financial Modeling Prep. COR28 data points from Jun 2019 to Mar 2026.
Sector
Healthcare
Industry
Medical - Distribution
CEO
Robert Mauch
Employees
51,000
Market cap
$59.92B
Beta
0.58
52-week range
$244.82 – $377.54
Dividend
Yes · $2.35
Exchange
NYSE
Country
US
IPO date
4 Apr 1995
ISIN
US03073E1055
CUSIP
03073E105
Company profile data from Financial Modeling Prep. COR listed on NYSE.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about COR

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.